Filing Details
- Accession Number:
- 0001209191-17-066272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-19 13:58:00
- Reporting Period:
- 2017-12-18
- Accepted Time:
- 2017-12-19 13:58:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1524472 | Xylem Inc. | XYL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226924 | R Steven Loranger | 1 International Drive C/O Xylem Inc. Rye Brook NY 10573 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-18 | 47,712 | $32.38 | 68,843 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-12-18 | 47,712 | $68.10 | 21,131 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-18 | 47,712 | $0.00 | 47,712 | $32.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,139 | 2018-10-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 130,918 | Indirect | By Steven R. Loranger Revocable Trust |
Footnotes
- The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.
- This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $68.00 to $68.35 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- These options are fully vested and exercisable.